DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zoloft (Sertraline) - Adverse Event Reports - Disability - Dizziness

 



Index of reports > Cases resulting in disability (26) > Cases with Dizziness (5)

Below is the selection of adverse event reports related to Zoloft (Sertraline) that includes cases resulting in disability where reactions include dizziness.

Adverse event in 46 year old female receiving Zoloft (Sertraline)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-16

Patient: 46 year old female, weighing 74.4 kg (163.7 pounds)

Adverse reactions / side effects: Abdominal Pain, Somnolence, Treatment Noncompliance, Laboratory Test Abnormal, Fatigue, Chest Pain, Dizziness, Temperature Intolerance, Injury, Depression, Cough, Viral Load Increased, Chromaturia, DRY Skin, Poisoning Deliberate, Haemodialysis, Irritability, Renal Failure, Abdominal Rigidity, Weight, Suicide Attempt, Bronchitis, Asthenia

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
PEG-Intron
    Dosage: 96 mcg; qw; sc
    Indication: Hepatitis C
    Start date: 2001-11-23
    End date: 2002-02-08

Rebetol
    Dosage: 1000 mg; qd; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2001-11-23
    End date: 2002-02-15

Zoloft
    Dosage: 100 mg; qd; po
    Administration route: Oral
    Indication: Depression

Antifreeze (Ethylene Glycol)
    Dosage: once; po
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2002-02-16
    End date: 2002-02-16

Other drugs received by patient: Atenolol; Nexium; Premarin; Prilosec; Norvasc



Adverse event in male receiving Zoloft (Sertraline)

Reported by a pharmacist from Canada on 2007-07-11

Patient: male

Adverse reactions / side effects: Dizziness, Feeling Abnormal

Adverse event resulted in: disablity

Suspect drug(s):
Zoloft (Sertraline)



Adverse event in female receiving Zoloft (Sertraline)

Reported by a health professional (non-physician/pharmacist) from Brazil on 2007-06-01

Patient: female

Adverse reactions / side effects: Hypersensitivity, Labyrinthitis, Nasopharyngitis, Pruritus, Drug Ineffective, Eye Discharge, Fear, Headache, Laryngeal Oedema, Pyrexia, Cardiac Valve Disease, Malaise, Neck Pain, Dizziness, Heart Rate Irregular, Coordination Abnormal, Cough, Back Pain, Blood Pressure Increased, Dyspnoea, Drug Hypersensitivity, Pain of Skin, Skin Disorder, Stress, Sleep Disorder, Alopecia, Miosis, Ocular Hyperaemia, Disturbance in Attention, Memory Impairment, Angiopathy

Adverse event resulted in: disablity

Suspect drug(s):
Zoloft
    Administration route: Oral
    Indication: Depression
    Start date: 2002-01-01
    End date: 2002-01-01

Feldene
    Indication: Bursitis

Estradiol
    Administration route: Topical
    Indication: Alopecia
    Start date: 2007-02-01
    End date: 2007-05-18

PIL-Food
    Administration route: Oral
    Indication: Hypersensitivity

ALL Other Therapeutic Products
    Administration route: Oral
    Indication: Hypersensitivity
    Start date: 2006-01-01
    End date: 2007-02-01

Pantogar
    Administration route: Oral
    Indication: Alopecia

Other drugs received by patient: Amitriptyline HCL; Rivotril



Adverse event in male receiving Zoloft (Sertraline)

Reported by a physician from Germany on 2007-05-03

Patient: male, weighing 68.0 kg (149.6 pounds)

Adverse reactions / side effects: Dizziness, Gait Disturbance, Paraesthesia

Adverse event resulted in: disablity

Suspect drug(s):
Zoloft (Sertraline)



Adverse event in 46 year old female receiving Zoloft (Sertraline)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-07

Patient: 46 year old female, weighing 74.4 kg (163.7 pounds)

Adverse reactions / side effects: Abdominal Pain, Hepatitis C, Chest Pain, Dizziness, Injury, Alanine Aminotransferase Abnormal, Cough, Blood Test Abnormal, Chromaturia, DRY Skin, Exposure TO Toxic Agent, Haemodialysis, Irritability, Blood Glucose Decreased, Renal Failure, Abdominal Rigidity, Suicide Attempt, Bronchitis, Aspartate Aminotransferase Abnormal

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
PEG-Intron
    Dosage: 96 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2001-11-23
    End date: 2002-02-08

Rebetol
    Dosage: see image
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2001-11-23
    End date: 2002-02-15

Zoloft
    Dosage: 100 mg;qd;po
    Administration route: Oral
    Indication: Depression

Other drugs received by patient: Atenolol; Nexium; Premarin; Prilosec; Norvasc

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009